{
    "Trade/Device Name(s)": [
        "BD Veritor System for Rapid Detection of Flu A+B CLIA-Waived Kit",
        "BD Veritor System",
        "BD Veritor System Flu A+B"
    ],
    "Submitter Information": "Becton, Dickinson and Company (BD Diagnostic Systems)",
    "510(k) Number": "K232434",
    "Predicate Device Reference 510(k) Number(s)": [
        "K223016"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PSZ"
    ],
    "Summary Letter Date": "September 6, 2023",
    "Summary Letter Received Date": "September 7, 2023",
    "Submission Date": "August 11, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.3328"
    ],
    "Regulation Name(s)": [
        "Devices Detecting Influenza A, B, and C Virus Antigens"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Flexible minitip flocked swab",
        "Reaction tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Veritor Plus Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Digital immunoassay",
        "Reflectance-based measurement"
    ],
    "Methodologies": [
        "Chromatographic immunoassay",
        "Antigen detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "Kit",
        "Instrument",
        "Reagent",
        "Control",
        "Swab",
        "Verification Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for BD Veritor System for Rapid Detection of Flu A+B CLIA-Waived Kit with modified Analyzer for enhanced ESD and battery protection",
    "Indications for Use Summary": "Rapid chromatographic immunoassay for direct and qualitative detection of influenza A and B viral nucleoprotein antigens from nasal and nasopharyngeal swabs of symptomatic patients, as an aid in diagnosis; not for detection of influenza C antigens.",
    "fda_folder": "Microbiology"
}